Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lyell Immunopharma, Inc. | 700,000 | reported | 24 Feb 2023 | tx 1+700,000 |
| Caribou Biosciences, Inc. | 68,523 | reported | 24 Feb 2026 | tx 6+683,226−1,066 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 20 Feb 2026 | GRANT_AWARD | Caribou Biosciences, Inc. | 55,000 | 0.00 USD | |
| 24 Feb 2026 | SALE | Caribou Biosciences, Inc. | 1,066 | 1.96 USD | |
| 20 Feb 2026 | GRANT_AWARD | Caribou Biosciences, Inc. | 247,500 | 0.00 USD | deriv |
| 20 Feb 2025 | GRANT_AWARD | Caribou Biosciences, Inc. | 14,589 | 0.00 USD | |
| 20 Feb 2025 | GRANT_AWARD | Caribou Biosciences, Inc. | 66,137 | 0.00 USD | deriv |
| 19 Aug 2024 | GRANT_AWARD | Caribou Biosciences, Inc. | 300,000 | 0.00 USD | deriv |
| 24 Feb 2023 | GRANT_AWARD | Lyell Immunopharma, Inc. | 700,000 | 0.00 USD | deriv |